Clinical Trials Logo

Clinical Trial Summary

This is a phase II, randomised, double blind, placebo controlled, complete block, three way crossover study to investigate treatment with nebulised RPL554 and tiotropium together in patients with moderate to severe chronic obstructive pulmonary disease (COPD). The purpose of this study is to assess the bronchodilator effect (opening of the airways) of RPL554 when used in combination with a long acting anti-muscarinic receptor antagonist (tiotropium) whilst dosing the RPL554 to steady state blood levels. It is planned to randomise up to 30 patients to have 24 evaluable patients at one study centre. In each treatment period, patients will receive an open label dose of tiotropium from a dry power inhaler (DPI) followed immediately by a double blind dose of either RPL554 6mg, 1.5mg or placebo (depending on treatment sequence) from a nebuliser in the morning on Day 1, Day 2 and Day 3. The dose of RPL554 or placebo will be repeated in the evening on Day 1 and Day 2Íž there will not be an evening dose on Day 3.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03028142
Study type Interventional
Source Verona Pharma plc
Contact
Status Completed
Phase Phase 2
Start date January 2017
Completion date August 2017

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05539547 - Effect of NMES on Quadriceps Muscle Strength and Endurance in Patients With COPD Early Phase 1
Recruiting NCT04386590 - Manual Therapy in Addition to Pulmonary Rehabilitation in Moderate Chronic Obstructive Pulmonary Disease. Phase 2/Phase 3
Active, not recruiting NCT04206007 - Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease Phase 1
Completed NCT05259280 - Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD N/A
Completed NCT02962999 - Effect Of Ketamine Infusion In Patients With COPD Applied One Lung Ventilation Phase 4
Completed NCT02998944 - The Study of CCTM and Common Diseases N/A
Completed NCT05431218 - Association of Cathelicidin and Vitamin D Levels With the Category and Course of COPD Phase 4
Active, not recruiting NCT06269029 - Chest Mobility Exercises Versus Proprioceptive Neuromuscular Facilitation in Patients With COPD N/A
Completed NCT03020862 - Beetroot Juice - Effects on Performance in Chronic Obstructive Pulmonary Disease Patients N/A
Completed NCT03031093 - Aerosol Therapy in Obese COPD Patients. N/A
Recruiting NCT06072690 - Respiratory and Cardiovascular Alterations in Patients With Chronic Obstructive Pulmonary Disease